The Liverpool human immunodeficiency virus (HIV) therapeutic drug monitoring (TDM) registry: studying influences upon plasma human immunodeficiency virus drug exposure
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18771051 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19228205 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19329800 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19474786 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19897506 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20051929 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20921307 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21364060 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20726906 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21441248 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21564164 results
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Request for TDM of HIV drugs
排除标准
- •. Separate filters will be applied when analysing data, e.g. for children, pregnant women, patients on dialysis, patients receiving chemotherapy etc.